Sign in
4

Changes in Ownership

Neurogene Inc. Filed Acc 0001209191-18-020680

Chief Operating Officer sold 1,302 shares at $14.63 ($19,049)

  • Chief Operating Officer acquired 1,302 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

MacKenzie Lloyd · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-03-15 Exercise or conversion : show line 1 in the form +1,302 $10.56 $13,749 1,302 D
2018-03-15 Sale : show line 2 in the form −1,302 $14.63 $19,049 0 D
Open-market sales · 1,302 sh · avg $14.63 · $19,049

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-03-15 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −1,302 0 D
Loading xslF345X03/doc4.xml…